drugset / Trial / NCT00655512
Comparison of Skin Thickness Under Treatment With Pimecrolimus 1% Cream, Hydrocortisonacetat 1% Cream, Betamethasonvalerat 0,1% Cream and Clobetasol-17-propionat 0,05% Cream Assessed by Optical Coherence Tomography (OCT) and 20-MHZ Ultrasound
RandomizedParallel-groupSingle-blindTreatment
Summary
to compare the atrophogenic potentials of pimecrolimus 1% cream, hydrocortisonacetat 1% cream, betamethasonvalerat 0,1% cream and clobetasol-17-Propionat 0,05% cream
Timeline
- Start
- 2008-01
- Primary completion
- 2008-06
- Completion
- 2008-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Pimecrolimus | Small molecule | 1 % | Topical |
| Comparator | betamethasonvalerat | Unknown | 0.1 % | Topical |
| Comparator | clobetasol-17-propionat | Unknown | 0.05 % | Topical |
| Comparator | hydrocortisonacetat | Unknown | 1 % | Topical |
Indications
No indication recorded.